Natera, Inc. filings document the regulatory record for a Nasdaq-listed diagnostics company focused on cell-free DNA and precision medicine. Recent Form 8-K reports furnish results of operations and financial condition, press releases, investor presentations and exhibit information tied to quarterly and annual reporting.
The company’s proxy materials describe board composition, director elections, committee assignments, executive compensation, equity-award disclosures and stockholder voting matters. Its filings also identify the registered common stock class, Nasdaq Global Select Market listing, governance actions and other material-event disclosures relevant to Natera’s public-company reporting.
Natera, Inc. president of clinical diagnostics Solomon Moshkevich reported several open‑market sales of Natera common stock. On February 2 and 3, 2026, he sold blocks of shares at weighted average prices ranging from about $228.50 to $234.00 per share.
The Form 4 shows individual transactions between 16 and 1,639 shares each, leaving 137,847 shares beneficially owned directly after the final sale. Most sales were made under a pre‑arranged Rule 10b5‑1 trading plan, and one 1,639‑share sale was executed to cover tax withholding on vesting RSUs.
Natera, Inc. CEO and President Steven Leonard Chapman reported multiple stock sales in early February 2026. On February 2 and 3, he sold several blocks of Natera common stock at weighted average prices generally between $228.50 and $234.00 per share, in open-market transactions.
The filing states that most sales on February 2 were made under a Rule 10b5-1 trading plan adopted on December 11, 2023 and amended on December 2, 2024, which automates trading according to preset instructions. A separate February 3 sale of 4,725 shares at a weighted average price of $230.768 was made to cover tax withholding tied to vesting restricted stock units. After these transactions, Chapman directly owned 123,156 shares of Natera common stock.
Natera, Inc. chief financial officer Michael Burkes Brophy reported multiple stock sales on February 3, 2026. He sold 1,268 shares of common stock at $230.768 per share to cover tax withholding tied to restricted stock unit vesting. He also sold 700 shares at a weighted average price of $225.2479 and 4,971 shares at a weighted average price of $227.447 under a Rule 10b5-1 trading plan adopted in 2025. After these transactions, he directly held 52,120 Natera shares.
Natera, Inc. executive John Fesko, its President and Chief Business Officer, reported two sales of Natera common stock on February 3, 2026. He sold 1,179 shares at $230.768 and 2,415 shares at $231.14, both reported as direct holdings.
According to the filing, each sale was made to satisfy tax withholding and remittance obligations from vesting restricted stock units and was executed under written instructions intended to meet Rule 10b5-1(c) affirmative defense conditions. After these transactions, Fesko directly beneficially owns 178,081 shares of Natera common stock.
Natera, Inc. director and co-founder Sheena Jonathan reported a small sale of company stock. On February 3, 2026, she sold 435 shares of Natera common stock at $230.768 per share. The sale was made to cover tax withholding and remittance obligations tied to the vesting of restricted stock units and was executed under a written instruction intended to meet Rule 10b5-1(c) affirmative defense conditions in her January 31, 2025 stock unit agreement.
After this transaction, Jonathan directly holds 263,161 shares of Natera common stock. In addition, 21,782 shares are held by Caraluna 1 Trust and 21,782 shares are held by Caraluna 2 Trust for the benefit of trust beneficiaries, and she disclaims beneficial ownership of those trust-held shares.
Natera, Inc. officer Daniel Rabinowitz, the company’s Secretary and Chief Legal Officer, reported selling 1,334 shares of Natera common stock on February 3, 2026 at a price of $230.768 per share. After this transaction, he beneficially owned 223,813 shares directly.
The filing explains that the sale was carried out to cover tax withholding and remittance obligations arising from the vesting of restricted stock units (RSUs). It was executed under a written instruction intended to meet the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act, indicating it was a pre-arranged, rule-compliant sale plan linked to prior equity grants.
Natera, Inc. reported that its President and Chief Business Officer, John Fesko, received an award of 6,135 restricted stock units (RSUs) of Natera common stock on January 30, 2026. These RSUs vested immediately upon issuance, and each RSU represents one share of common stock.
Following this equity grant, Fesko directly beneficially owns 181,675 shares of Natera common stock. The transaction was recorded at a price of $0.00 per share, reflecting a compensatory stock award rather than an open-market purchase.
Natera, Inc. director received 73 shares of common stock on January 30, 2026 through an award of restricted stock units (RSUs) granted in lieu of a $17,500 quarterly cash retainer for Board service.
The RSUs were fully vested at issuance, and each RSU converts into one share of Natera common stock. Following this grant, the director directly holds 5,389 shares of Natera common stock.
Natera, Inc. director Herm Rosenman reported a stock-based board fee. On 01/30/2026 he received 99 shares of Natera common stock through fully vested Restricted Stock Units granted in lieu of a quarterly board retainer of $23,750.
Each RSU represents one share of Natera common stock, so the grant directly increased his holdings. After this transaction, Rosenman beneficially owned 20,441 shares of Natera common stock held directly.
Natera, Inc. director Marcus Gail Boxer received an award of 91 restricted stock units on 01/30/2026 as part of his Board compensation. The RSUs were issued in lieu of quarterly retainer fees of $21,875 and were fully vested at issuance.
Each RSU represents a right to receive one share of Natera common stock. Following this grant, Boxer beneficially owned 5,853 shares of Natera common stock in direct ownership.